Your browser doesn't support javascript.
loading
Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela; Perkins, Jennifer M; Roman, Sanziana A; Sosa, Julie Ann.
Afiliación
  • Ruel E; Department of Medicine (E.R., J.M.P.), Division of Endocrinology, Metabolism, and Nutrition, Department of Surgery (J.A.S.), Section of Endocrine Surgery, Duke University Medical Center, and Duke Cancer Institute (J.A.S.), Durham, North Carolina 27710; Department of Biostatistics (S.T.), Duke University, Durham, North Carolina 27708; and Duke Clinical Research Institute (M.D., J.A.S.), Durham, North Carolina 27705.
J Clin Endocrinol Metab ; 100(4): 1529-36, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25642591

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma / Radioisótopos de Yodo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Endocrinol Metab Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma / Radioisótopos de Yodo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Endocrinol Metab Año: 2015 Tipo del documento: Article